Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell…
NCT00084799 · Ludwig Institute for Cancer Research, Other · Completed
Key facts
| NCT number | NCT00084799 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC) |
| Official title | A Multiple-Dose Targeting Study of hu3S193 in Patients With Small Cell Lung Cancer |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological |
| Interventions | monoclonal antibody hu3S193 |
| Enrollment | 10 |
| Start date | Jul 26, 2004 |
| Primary completion | Jan 25, 2006 |
| Completion | Dec 20, 2006 |
| First posted | Jun 11, 2004 |
| Last update posted | Oct 4, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: